Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CERTOLIZUMAB PEGOL vs INFLIXIMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CERTOLIZUMAB PEGOL vs INFLIXIMAB: Safety Overview

Metric CERTOLIZUMAB PEGOL INFLIXIMAB
Total FAERS Reports 99,098 140,189
Deaths Reported 5,361 7,516
Death Rate 5.4% 5.4%
Hospitalizations 17,641 36,324
Average Patient Age 49.5 yrs 43.9 yrs
% Female Patients 83.1% 64.4%
Manufacturer UCB, Inc. Organon LLC
Route SUBCUTANEOUS INTRAVENOUS
Marketing Status Prescription Prescription